Skip to main content
Atrayee Basu Mallick, MD, Oncology, Philadelphia, PA, Thomas Jefferson University Hospital

AtrayeeBasu MallickMD

Oncology Philadelphia, PA

Gastrointestinal Cancer, Hematologic Oncology, Sarcoma

, Medical Oncology, Thomas Jefferson University Hospital

Dr. Basu Mallick is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Basu Mallick's full profile

Already have an account?

Education & Training

  • Montefiore Medical Center/Albert Einstein College of Medicine (Moses and Weiler Campuses)
    Montefiore Medical Center/Albert Einstein College of Medicine (Moses and Weiler Campuses)Fellowship, Hematology and Medical Oncology, 2007 - 2010
  • SUNY Health Science Center at Brooklyn
    SUNY Health Science Center at BrooklynResidency, Internal Medicine, 2004 - 2007
  • Medical College and Hospital Kolkata
    Medical College and Hospital KolkataClass of 2000

Certifications & Licensure

  • NJ State Medical License
    NJ State Medical License 2017 - 2025
  • PA State Medical License
    PA State Medical License 2010 - 2024
  • DE State Medical License
    DE State Medical License 2017 - 2019
  • American Board of Internal Medicine Hematology
  • American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

  • CMS Meaningful Use Stage 1 Certification Allscripts Enterprise EHR, Allscripts, 2011-2013
  • Award for Outstanding Service and Dedication Kings County Hospital, 2007
  • Intern of the Year SUNY Downstate, 2005
  • Join now to see all

Publications & Presentations

PubMed

Journal Articles

  • Pazopanib for the Treatment of Soft Tissue Sarcoma - Where Does It Fit?  
    Mallick, Atrayee Basu; Narasimhan, Vivek; Soman, Neelesh; Chawla, Sant P, Journal of OncoPathology, 1/1/2014
  • PTEN Gene Expression and Mutations in the PIK3CA Gene as Predictors of Clinical Benefit to Anti-Epidermal Growth Factor Receptor Antibody Therapy in Patients With KRAS...  
    Arjun Sood, Danielle McClain, Radhashree Maitra, Atrayee Basu-Mallick, Raviraja Seetharam, Andreas Kaubisch, Lakshmi Rajdev, John M. Mariadason, Kathryn Tanaka, Sanjay..., Clinical Colorectal Cancer, 1/1/2012
  • Evaluation of inducible expression of ERCC1 as a biomarker of drug response in human colorectal cancer cell lines  
    Atrayee Basu Mallick MD, Raviraja Seetharam Phd, Arjun Sood MD, Sanjay Goel MD, Journal of Clinical Oncology, 2010 ASCO Annual Meeting Proceedings (Post-Meeting Edition), 1/1/2010
  • Join now to see all

Lectures

  • Assessment for Risk Factors Associated With Local Recurrence in Chordoma. 
    Boston, MA - 1/1/2015

Professional Memberships

Hospital Affiliations